Effect of GnRH agonist and letrozole treatment in women with recurrent implantation failure
Effect of GnRH agonist and letrozole treatment in women with recurrent implantation failure
复制标题
DOI:
10.1016/j.fertnstert.2019.03.021
复制
发表时间:
2019-07-01
影响因子:
6.7
通讯作者:
Dahan, Michael H.
中科院分区:
文献类型:
--
作者:
Steiner, Naama;Shrem, Guy;Dahan, Michael H.
Objective: To compare the influence of dual suppression with the use of GnRH agonist plus aromatase inhibitor compared with suppression with the use of GnRH agonist alone or no suppression at all in patients with idiopathic recurrent implantation failure (RIF).Design: Retrospective cohort study.Setting: University-affiliated reproductive center.Patient(s): A total of 523 infertile women who failed two blastocyst transfers underwent a third frozen blastocyst transfer. Women with known endometriosis were excluded.Intervention(s): A total of 204 subjects were not pretreated, 143 received 2 months of GnRH agonist (3.75 mg intramuscular leuprolide acetate monthly) only, and 176 received GnRH agonist and aromatase inhibitor (5 mg oral letrozole daily for 60 days). Demographic and stimulation information was collected and cycle outcomes reported.Main Outcome Measure(s): Clinical pregnancy rates.Result(s): Age, antral follicle count, basal FSH levels, duration of infertility, previous pregnancies, and full-term deliveries were similar (P>.05). Clinical pregnancy rates were higher among women who received GnRH agonist plus letrozole compared with women who received GnRH agonist only or women without pretreatment (63%, 42%, and 40%, respectively; P